Valuation: Spectral AI, Inc.

Market Cap 53.43M 47.05M 44.58M 40.24M 75.85M 5.12B 76.83M 533M 205M 2.62B 201M 196M 8.4B P/E 2026 *
-3.56x
P/E 2027 * -5.35x
Enterprise Value 53.43M 47.05M 44.58M 40.24M 75.85M 5.12B 76.83M 533M 205M 2.62B 201M 196M 8.4B EV / Sales 2026 *
2.88x
EV / Sales 2027 * 1.65x
Free-Float
86.68%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 59 08/02/2026
Chief Executive Officer 57 10/09/2023
Director of Finance/CFO 47 03/05/2026
Director TitleAgeSince
Chairman 65 10/09/2023
Director/Board Member 68 31/05/2021
Director/Board Member 52 10/09/2023
Change 5-day change 1-year change 3-year change Capi.($)
+10.48%+19.83% - - 53.43M
-0.67%+1.47%+39.18%+33.36% 250B
-2.02%-0.00%+11.75%-10.70% 156B
-1.35%+2.09%-9.08%+39.12% 144B
-0.52%-2.17%-55.29%-17.33% 63.26B
-2.00%-0.58%+10.99%+24.60% 49.75B
-1.55%+4.23%+34.25%+54.10% 48.58B
-1.04%+0.97%-18.86%-21.84% 47.99B
+2.47%+5.43%-4.18%+40.30% 46.22B
-0.87%+4.47%+46.56%+60.24% 43.17B
Average +0.29%+2.27%+6.15%+22.43% 94.22B
Weighted average by Cap. -1.01%+2.37%+11.71%+21.76%

Financials

2026 *2027 *
Net sales 18.53M 16.32M 15.46M 13.96M 26.3M 1.78B 26.64M 185M 71.18M 908M 69.58M 68.06M 2.91B 32.42M 28.55M 27.05M 24.42M 46.03M 3.11B 46.62M 324M 125M 1.59B 122M 119M 5.1B
Net income -15.21M -13.39M -12.69M -11.45M -21.59M -1.46B -21.87M -152M -58.41M -745M -57.1M -55.85M -2.39B -11.15M -9.82M -9.3M -8.4M -15.83M -1.07B -16.03M -111M -42.83M -547M -41.87M -40.95M -1.75B
Net Debt - -
Logo Spectral AI, Inc.
Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. It is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.
Employees
65
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-